Peloton Interactive Inc
Change company Symbol lookup
Select an option...
PTON Peloton Interactive Inc
SNAP Snap Inc
TWLO Twilio Inc
CHWY Chewy Inc
WOOF Petco Health and Wellness Company Inc
TEAM Atlassian Corporation PLC
CRWD CrowdStrike Holdings Inc
WDAY Workday Inc
PATH UiPath Inc

Consumer Discretionary : Leisure Products | Mid Cap Growth
Company profile

Peloton Interactive, Inc. is a provider of interactive fitness platform. The Company provides connected, technology-enabled fitness and the streaming of instructor-led boutique classes to its members. The Company operates and manages its business in three reportable segments: connected fitness product segment, subscription segment, and other segment. Its connected fitness product segment consists of its Bike and Tread and related accessories. Its other segment consists of Peloton branded apparels.

Day's Change
3.32 (3.79%)
B/A Size
Day's High
Day's Low
(Below Average)

Today's volume of 20,631,788 shares is on pace to be lower than PTON's 10-day average volume of 28,213,727 shares.


Global Kaposi Sarcoma Market (2021 to 2025) - Featuring Baxter International, Galen and GlaxoSmithKline Among Others -

9:46 am ET March 3, 2021 (BusinessWire) Print

The "Global Kaposi Sarcoma Market 2021-2025" report has been added to's offering.

The publisher has been monitoring the kaposi sarcoma market and it is poised to grow by $20.89 million during 2021-2025 progressing at a CAGR of 3% during the forecast period.

The report on kaposi sarcoma market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising number of organ transplants and rising number of HIV patients.

The kaposi sarcoma market analysis includes type segment and geographical landscapes. This study identifies the increasing cancer prevalence in developing countries as one of the prime reasons driving the kaposi sarcoma market growth during the next few years.

Companies Mentioned

ADVANZ PHARMA Corp. Ltd. Aurobindo Pharma Ltd. Baxter International Inc. Bristol-Myers Squibb Co. Eli Lilly and Co. F. Hoffmann-La Roche Ltd. Galen Ltd. GlaxoSmithKline Plc Merck & Co. Inc.

The report on kaposi sarcoma market covers the following areas:

Kaposi sarcoma market sizing Kaposi sarcoma market forecast Kaposi sarcoma market industry analysis

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Key Topics Covered:

1. Executive Summary

Market Overview

2. Market Landscape

Market ecosystem Value chain analysis

3. Market Sizing

Market definition Market segment analysis Market size 2020 Market outlook: Forecast for 2020 - 2025

4. Five Forces Analysis

Five forces summary Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

5. Market Segmentation by Treatment Type

Market segments Comparison by treatment type HAART - Market size and forecast 2020-2025 Chemotherapy - Market size and forecast 2020-2025 Immunotherapy - Market size and forecast 2020-2025 Market opportunity by treatment type

6. Customer landscape

7. Geographic Landscape

Geographic segmentation Geographic comparison North America - Market size and forecast 2020-2025 Europe - Market size and forecast 2020-2025 Asia - Market size and forecast 2020-2025 ROW - Market size and forecast 2020-2025 Key leading countries Market opportunity by geography Market drivers Market challenges Market trends

8. Vendor Landscape

Overview Landscape disruption

9. Vendor Analysis

Vendors covered Market positioning of vendors ADVANZ PHARMA Corp. Ltd. Aurobindo Pharma Ltd. Baxter International Inc. Bristol-Myers Squibb Co. Dr. Reddy's Laboratories Ltd. Eli Lilly and Co. F. Hoffmann-La Roche Ltd. Galen Ltd. GlaxoSmithKline Plc Merck & Co. Inc.

10. Appendix

Scope of the report Currency conversion rates for US$ Research methodology List of abbreviations

For more information about this report visit

View source version on

SOURCE: Research and Markets
Laura Wood, Senior Press Manager 
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.